NVCT Nuvectis Pharma, Inc.
$23.99▲ +6.67%
Healthcare
Other
After hours
$23.99▲ +0.00%
Sep 11, 7:30 PM ET
Volume 221.1K
Avg Volume (10D) 157.8K
Key Metrics & Fundamentals
Market Cap
$783.13M
P/E Ratio
–
Div Yield
–%
52W Range
5.55 - 29.28
% vs 50 MA
14.32%
% vs 200 MA
94.23%
RSI-14
57.3
MACD Histogram
-0.2100
Beta (1Y vs SPY)
0.99
Free Cash Flow
-$4.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$7.20M
COGS
–
Operating Exp
$7.20M
Operating Income
-$7.20M
EBIT
-$7.20M
Pretax Income
-$7.02M
Net Income
-$7.02M
EPS (Diluted)
-0.30
Price & Volume History
Loading chart…
Recent News
Nuvectis Pharma To Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 3, 2026 12:00 PM
Nuvectis Stock Surges Around 97% in 3 Months: Here's Why
Zacks · Aug 19, 2026 3:33 PM
Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights
GlobeNewswire · Aug 4, 2026 12:00 PM
Wall Street Analysts Predict a 56.41% Upside in Nuvectis Pharma (NVCT): Here's What You Should Know
Zacks · Jul 29, 2026 1:55 PM
Nuvectis Pharma Says Paroxysmal Nocturnal Hemoglobinuria Drug Approved by Chinese Regulator
MT Newswires · Jul 23, 2026 1:07 PM
Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
GlobeNewswire · Jul 23, 2026 1:00 PM
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
GlobeNewswire · Jul 23, 2026 11:30 AM
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
TMX Newsfile · Jul 14, 2026 2:40 PM
Wall Street Analysts See a 61.46% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?
Zacks · Jul 8, 2026 1:55 PM
Nuvectis Pharma Insider Bought Shares Worth $916,000, According to a Recent SEC Filing
MT Newswires · Jul 1, 2026 5:47 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See NVCT's money flow as a full page
Social Sentiment
No Reddit posts found for NVCT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.